Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- BBC
- Price
- 43.90
- Stock movement up
- +1.53 (3.61%)
- Company name
- Virtus LifeSci Biotech Clinical Trials ETF
- Exchange
- (NYSE ARCA ,
- Currency
- USD )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- 0.55%
- Div growth
- -
- Growth years
- 1
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- 95.42%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 0.24 |
| Dividend yield | 0.55% |
| Payout frequency | - |
| Maximum yield | 1.70% |
| Average yield | 1.00% |
| Minimum yield | 0.55% |
| Discount to avg yield | -83.45% |
| Upside potential | -45.49% |
| Yield as % of max yield | 32.21% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 0.55% |
| Current yield distribution | 99.69% |
| Yield at 100% (Min) | 0.55% |
| Yield at 90% | 0.64% |
| Yield at 80% | 0.79% |
| Yield at 50% (Median) | 1.02% |
| Yield at 20% | 1.22% |
| Yield at 10% | 1.31% |
| Yield at 0% (Max) | 1.70% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 1 years |
| CCC status | - |
| Dividend per share | 0.24 |
| Payout frequency | - |
| Ex-div date | 22 Dec 2025 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| BBC | S&P500 | |
| DGR MR | 192.68% | -13.74% |
| DGR TTM | 192.68% | 6.60% |
| DGR 3 years | - | 7.31% |
| DGR 5 years | - | 4.69% |
| DGR 10 years | - | 6.30% |
| DGR 15 years | - | 8.16% |
| Time since last change announced | 742 days |
| EPS growth (5y) | - |
| EPS growth (5y forward) | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 42.77 |
| Daily high | 44.10 |
| Daily low | 42.77 |
| Daily Volume | 29K |
| All-time high | 61.92 |
| 1y analyst estimate | - |
| Beta | 1.52 |
| EPS (TTM) | - |
| Dividend per share | 0.24 |
| Ex-div date | 22 Dec 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BBC | S&P500 | |
| Current price drop from All-time high | -29.10% | -0.89% |
| Highest price drop | -77.16% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -58.84% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
-
Marketcap category
Mid-cap
Description
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Employees
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page